Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Potential Treatment of Atherosclerotic Cardiovascular Disease (ASCVD) in Patients with Mixed Hyperlipidemia Poster Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Potential Treatment of Atherosclerotic Cardiovascular Disease (ASCVD) in Patients with Mixed Hyperlipidemia Certara2024年11月22日
Integrated Population Pharmacokinetic Model of Bemnifosbuvir and Metabolites Poster Integrated Population Pharmacokinetic Model of Bemnifosbuvir and Metabolites Certara2024年11月22日
Indirect Exposure-Response Modeling for Transthyretin Amyloid Cardiomyopathy Treated with Acoramidis (AG10) Poster Indirect Exposure-Response Modeling for Transthyretin Amyloid Cardiomyopathy Treated with Acoramidis (AG10) Certara2024年11月22日
Model-Informed Drug Development Framework for the Development and Dose Optimization of Targeted Radiation Therapies Poster モデルを活かした医薬品開発(MIDD)の枠組みによる、標的放射線療法の開発と投与量の最適化 Certara2024年11月22日
Oncology MIDD Simulator, A User-Friendly Application for Overall Survival Forecasting in Early Oncology Trials Poster Oncology MIDD Simulator, A User-Friendly Application for Overall Survival Forecasting in Early Oncology Trials Certara2024年11月22日
Population pharmacokinetic modeling of niraparib to assess different absorption models Poster Population pharmacokinetic modeling of niraparib to assess different absorption models Certara2024年11月22日
Enhancing Pharmacokinetics Workflows at Charles River Case Study Charles River社で薬物動態ワークフローを強化 PreclinicalPhoenix™ Integral Data Repository Charles River, a global leader in drug development, sought to improve…Certara2024年11月13日
PBPK Modeling to Support Bioequivalence & Generic Product Approvals Blog PBPKモデル化による生物学的同等性評価およびジェネリック医薬品承認の支援 Physiologically-based pharmacokinetic modeling can be used to support bioequivalence (BE) assessment of complex and locally…Certara2024年11月12日
Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody Publication Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody The article titled "Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a…Certara2024年11月4日
On-ramps to popPK: Building Better Models with GUI, Code, or Both On-Demand Webinar PopPKへの導入方法:GUI、コード、またはその両方でより優れたモデルを構築する A critical component of popPK studies is popPK modeling, where mathematical models are developed to…Certara2024年10月18日